CN101242811B - 酸不稳定性药物的控释药物组合物 - Google Patents
酸不稳定性药物的控释药物组合物 Download PDFInfo
- Publication number
- CN101242811B CN101242811B CN200680029688.XA CN200680029688A CN101242811B CN 101242811 B CN101242811 B CN 101242811B CN 200680029688 A CN200680029688 A CN 200680029688A CN 101242811 B CN101242811 B CN 101242811B
- Authority
- CN
- China
- Prior art keywords
- pancreatin
- dosage form
- peroral dosage
- pharmaceutical compositions
- controlled release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Description
Claims (12)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70869205P | 2005-08-15 | 2005-08-15 | |
US60/708,692 | 2005-08-15 | ||
EP05107472.2 | 2005-08-15 | ||
EP05107472 | 2005-08-15 | ||
PCT/EP2006/065311 WO2007020259A2 (en) | 2005-08-15 | 2006-08-15 | Controlled release pharmaceutical compositions for acid labile drugs |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101242811A CN101242811A (zh) | 2008-08-13 |
CN101242811B true CN101242811B (zh) | 2015-06-17 |
Family
ID=35253818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680029688.XA Active CN101242811B (zh) | 2005-08-15 | 2006-08-15 | 酸不稳定性药物的控释药物组合物 |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP1931316B2 (zh) |
JP (1) | JP5452918B2 (zh) |
CN (1) | CN101242811B (zh) |
AT (1) | ATE457719T2 (zh) |
AU (1) | AU2006281414B2 (zh) |
BR (1) | BRPI0614545B8 (zh) |
CA (1) | CA2619475C (zh) |
DK (1) | DK1931316T4 (zh) |
ES (1) | ES2341284T5 (zh) |
MX (1) | MX2008001558A (zh) |
NZ (1) | NZ565960A (zh) |
PL (1) | PL1931316T5 (zh) |
PT (1) | PT1931316E (zh) |
RU (1) | RU2440101C2 (zh) |
SI (2) | SI1931316T2 (zh) |
UA (1) | UA92030C2 (zh) |
WO (1) | WO2007020259A2 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1319655B1 (it) | 2000-11-15 | 2003-10-23 | Eurand Int | Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione. |
WO2007014896A1 (en) | 2005-07-29 | 2007-02-08 | Solvay Pharmaceuticals Gmbh | Processes for the manufacture of sterilized pancreatin powder |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
CA2677989C (en) * | 2007-02-20 | 2018-04-24 | Eurand Pharmaceuticals Limited | Stable digestive enzyme compositions |
EP2044932A1 (en) | 2007-10-04 | 2009-04-08 | Laboratorios del Dr. Esteve S.A. | Mechanical protective layer for solid dosage forms |
WO2009064458A2 (en) | 2007-11-13 | 2009-05-22 | Meritage Pharma, Inc. | Compositions for the treatment of inflammation of the gastrointestinal tract |
US10087493B2 (en) | 2008-03-07 | 2018-10-02 | Aptalis Pharma Canada Ulc | Method for detecting infectious parvovirus in pharmaceutical preparations |
US20110097401A1 (en) | 2009-06-12 | 2011-04-28 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
WO2011140106A1 (en) * | 2010-05-03 | 2011-11-10 | Eurand Pharmaceuticals Limited | Micropellet compositions comprising pancreatin containing digestive enzyme mixtures |
MX348118B (es) | 2010-10-01 | 2017-05-26 | Aptalis Pharma Ltd | Formulaciones de pancrelipasa con recubrimiento enterico de baja potencia. |
EP2987499B1 (en) * | 2011-08-08 | 2019-05-08 | Allergan Pharmaceuticals International Limited | Method for dissolution testing of solid compositions containing digestive enzymes |
US10184121B2 (en) | 2013-06-28 | 2019-01-22 | Allergan Pharmaceuticals International Limited | Methods for removing viral contaminants from pancreatic extracts |
RU2679832C2 (ru) | 2013-08-09 | 2019-02-13 | Аллерган Фармасьютикалз Интернэйшнл Лимитед | Композиция пищеварительных ферментов, подходящая для энтерального введения |
EP3215181A1 (en) | 2014-11-05 | 2017-09-13 | Abbott Laboratories GmbH | Processes for producing compositions with improved safety profile comprising pancreatin and compositions suitable for pharmaceutical use |
CN104906565B (zh) * | 2015-05-13 | 2018-06-19 | 西南大学 | 一种胰酶肠溶微丸及其制备方法 |
CN105902513B (zh) * | 2016-05-11 | 2018-10-16 | 广州市义和化工有限公司 | 一种肠溶型金霉素微丸预混剂及其制备方法 |
CN108553439B (zh) * | 2018-04-20 | 2020-10-16 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种含s-羧甲基-l-半胱氨酸的肠溶片剂 |
RU2706003C1 (ru) | 2019-09-09 | 2019-11-13 | Акционерное общество "АВВА РУС" | Микрогранулы, содержащие панкреатин |
KR102432084B1 (ko) * | 2021-11-16 | 2022-08-12 | 알리코제약(주) | S-오메프라졸을 함유하는 안정성이 개선되고 소형화된 정제 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035780A1 (en) * | 1980-03-10 | 1981-09-16 | Shin-Etsu Chemical Co., Ltd. | Coating compositions for enterosoluble solid dosage forms |
US4786505A (en) * | 1986-04-30 | 1988-11-22 | Aktiebolaget Hassle | Pharmaceutical preparation for oral use |
US5378462A (en) * | 1992-08-19 | 1995-01-03 | Kali-Chemie Pharma Gmbh | Pancreatin micropellets prepared with polyethylene glycol 4000, paraffin and a lower alcohol by extrusion and rounding |
CN1235824A (zh) * | 1998-02-26 | 1999-11-24 | 一洋药品株式会社 | 包肠溶衣的胰酶颗粒的制备方法 |
US20040101562A1 (en) * | 2000-11-15 | 2004-05-27 | Mario Maio | Microspheres of pancreatic enzymes with high stability and production method thereof |
US20040213847A1 (en) * | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923279B1 (de) | 1979-06-08 | 1980-11-20 | Kali Chemie Pharma Gmbh | Verfahren zur Herstellung von Pankreatin-Pellets |
JPS57171428A (en) | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
US5225202A (en) | 1991-09-30 | 1993-07-06 | E. R. Squibb & Sons, Inc. | Enteric coated pharmaceutical compositions |
JP2917799B2 (ja) | 1994-03-11 | 1999-07-12 | 田辺製薬株式会社 | 消化管内適所放出型製剤 |
JP3355593B2 (ja) | 1994-08-19 | 2002-12-09 | 信越化学工業株式会社 | 固形腸溶製剤の製造方法 |
JP3435464B2 (ja) * | 1995-01-23 | 2003-08-11 | 信越化学工業株式会社 | 徐放性製剤コーティング用水分散液 |
SE512835C2 (sv) * | 1996-01-08 | 2000-05-22 | Astrazeneca Ab | Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare |
JP3611456B2 (ja) * | 1997-09-30 | 2005-01-19 | 日研化学株式会社 | テオフィリン徐放性錠剤 |
UA69413C2 (uk) | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
RU2268065C2 (ru) | 1999-03-17 | 2006-01-20 | Зольвай Фармасьютиклз Гмбх | Лекарственное средство, предназначенное для лечения диабета |
US20020146451A1 (en) | 2000-07-15 | 2002-10-10 | Sharma Virender K. | Method for the administration of acid-labile drugs |
-
2006
- 2006-08-15 SI SI200630639A patent/SI1931316T2/sl unknown
- 2006-08-15 BR BRPI0614545A patent/BRPI0614545B8/pt active IP Right Grant
- 2006-08-15 AU AU2006281414A patent/AU2006281414B2/en active Active
- 2006-08-15 AT AT06778240T patent/ATE457719T2/de active
- 2006-08-15 PL PL06778240T patent/PL1931316T5/pl unknown
- 2006-08-15 EP EP06778240.9A patent/EP1931316B2/en active Active
- 2006-08-15 WO PCT/EP2006/065311 patent/WO2007020259A2/en active Application Filing
- 2006-08-15 RU RU2008109652/15A patent/RU2440101C2/ru active
- 2006-08-15 DK DK06778240.9T patent/DK1931316T4/en active
- 2006-08-15 NZ NZ565960A patent/NZ565960A/en unknown
- 2006-08-15 CN CN200680029688.XA patent/CN101242811B/zh active Active
- 2006-08-15 SI SI200630639T patent/SI1931316T1/sl unknown
- 2006-08-15 MX MX2008001558A patent/MX2008001558A/es active IP Right Grant
- 2006-08-15 PT PT06778240T patent/PT1931316E/pt unknown
- 2006-08-15 ES ES06778240.9T patent/ES2341284T5/es active Active
- 2006-08-15 CA CA2619475A patent/CA2619475C/en active Active
- 2006-08-15 UA UAA200803186A patent/UA92030C2/ru unknown
- 2006-08-15 JP JP2008526492A patent/JP5452918B2/ja active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0035780A1 (en) * | 1980-03-10 | 1981-09-16 | Shin-Etsu Chemical Co., Ltd. | Coating compositions for enterosoluble solid dosage forms |
US4786505A (en) * | 1986-04-30 | 1988-11-22 | Aktiebolaget Hassle | Pharmaceutical preparation for oral use |
US5378462A (en) * | 1992-08-19 | 1995-01-03 | Kali-Chemie Pharma Gmbh | Pancreatin micropellets prepared with polyethylene glycol 4000, paraffin and a lower alcohol by extrusion and rounding |
CN1235824A (zh) * | 1998-02-26 | 1999-11-24 | 一洋药品株式会社 | 包肠溶衣的胰酶颗粒的制备方法 |
US20040101562A1 (en) * | 2000-11-15 | 2004-05-27 | Mario Maio | Microspheres of pancreatic enzymes with high stability and production method thereof |
US20040213847A1 (en) * | 2003-04-23 | 2004-10-28 | Matharu Amol Singh | Delayed release pharmaceutical compositions containing proton pump inhibitors |
Also Published As
Publication number | Publication date |
---|---|
NZ565960A (en) | 2012-03-30 |
MX2008001558A (es) | 2008-02-15 |
BRPI0614545B1 (pt) | 2020-03-31 |
SI1931316T1 (sl) | 2010-06-30 |
WO2007020259A2 (en) | 2007-02-22 |
SI1931316T2 (sl) | 2017-05-31 |
RU2008109652A (ru) | 2009-09-27 |
RU2440101C2 (ru) | 2012-01-20 |
CA2619475C (en) | 2015-09-29 |
EP1931316B1 (en) | 2010-02-17 |
BRPI0614545A2 (pt) | 2011-04-05 |
ATE457719T2 (de) | 2010-03-15 |
PL1931316T5 (pl) | 2017-10-31 |
BRPI0614545B8 (pt) | 2021-05-25 |
ES2341284T3 (es) | 2010-06-17 |
PT1931316E (pt) | 2010-03-29 |
EP1931316A2 (en) | 2008-06-18 |
AU2006281414A1 (en) | 2007-02-22 |
EP1931316B2 (en) | 2017-02-22 |
DK1931316T3 (da) | 2010-05-17 |
UA92030C2 (ru) | 2010-09-27 |
JP5452918B2 (ja) | 2014-03-26 |
WO2007020259A3 (en) | 2007-05-10 |
DK1931316T4 (en) | 2017-05-15 |
JP2009504709A (ja) | 2009-02-05 |
CA2619475A1 (en) | 2007-02-22 |
CN101242811A (zh) | 2008-08-13 |
PL1931316T3 (pl) | 2010-07-30 |
AU2006281414B2 (en) | 2011-09-01 |
ES2341284T5 (es) | 2017-09-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101242811B (zh) | 酸不稳定性药物的控释药物组合物 | |
US20210060142A1 (en) | Controlled release pharmaceutical compositions for acid-labile drugs | |
CA2619477C (en) | Pancreatin micropellet cores suitable for enteric coating | |
US11266607B2 (en) | Process for the manufacture and use of pancreatin micropellet cores | |
CN1886119B (zh) | 泮托拉唑多颗粒制剂 | |
CN101378753A (zh) | 兰索拉唑口崩片 | |
CN101242812B (zh) | 适合肠溶包衣的胰酶微丸芯 | |
CN109069460A (zh) | 改进的药物制剂 | |
US20230000780A1 (en) | Dosage form comprising an alkaline agent and an enteric coating layer | |
US20040229821A1 (en) | Orally administrable pharmaceutical compositions and methods for preventing food-drug interaction | |
JP6856326B2 (ja) | 腸放出粒子組成物 | |
CN101478958A (zh) | 包含哌啶烷醇和减充血剂的组合的药物组合物 | |
CN102397262B (zh) | 阿莫西林缓释固体药物组合物及其制备方法 | |
KR101344546B1 (ko) | 산 불안정성 약제를 위한 조절방출 약제학적 조성물 | |
CN104274444A (zh) | 达比加群酯或其盐的口服双微丸药物组合物 | |
EP3156049A1 (en) | Pharmaceutical composition of prasugrel | |
US20240131125A1 (en) | Controlled release pharmaceutical compositions for acid-labile drugs | |
Ahmedi et al. | CHALLENGES OF ORAL DRUG DELIVERY SYSTEMS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1121037 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Hannover Applicant after: Solvay Pharm GmbH Address before: Hannover Applicant before: Solvay Pharmaceuticals GmbH |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: SOLVAY PHARMACEUTICALS GMBH TO: ABBOTT PRODUCTS, INC. |
|
ASS | Succession or assignment of patent right |
Owner name: ABBOTT LABORATORIES CO., LTD. Free format text: FORMER OWNER: ABBOTT PRODUCTS, INC. Effective date: 20130304 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20130304 Address after: Hannover Applicant after: Abbott Laboratories Co., Ltd. Address before: Hannover Applicant before: Solvay Pharm GmbH |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1121037 Country of ref document: HK |